MedPath

PROGLYCEM

PROGLYCEM

Approved
DIN Number

00503347

Drug Class

Human

Market Date

Dec 31, 1985

Company
HC

Merck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00503347
AIG Number0108984003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AH01 DIAZOXIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification24:08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIAZOXIDEActive
Strength: 100 MG
Monograph: DIAZOXIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.